Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weixing Li

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Journal of Medicinal Chemistry|May 2, 2003
Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitorPavel Majer, Paul F Jackson, Greg Delahanty, et al.
The Journal of Clinical Investigation|September 9, 2025
Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9Rui Guo, Yizhe Sun, Matthew Y Lim, et al.
Cell Reports. Medicine|April 30, 2026
BCAT1-dependent HIF-1α stabilization is a targetable metabolic vulnerability in hepatocellular carcinomaMisty Shuo Zhang, Kenneth Kin-Leung Kwan, Aki Pui-Wah Tse, et al.
Cancer Biology & Medicine|February 18, 2026
Expert consensus on the detection and clinical application of tumor mutational burdenZhenying Guo, Chunwei Xu, Shirong Zhang, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Journal of Medicinal Chemistry|May 2, 2003
Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitorPavel Majer, Paul F Jackson, Greg Delahanty, et al.
The Journal of Clinical Investigation|September 9, 2025
Multiomic analysis reveals a key BCAT1 role in mTOR activation by B cell receptor and TLR9Rui Guo, Yizhe Sun, Matthew Y Lim, et al.
Cell Reports. Medicine|April 30, 2026
BCAT1-dependent HIF-1α stabilization is a targetable metabolic vulnerability in hepatocellular carcinomaMisty Shuo Zhang, Kenneth Kin-Leung Kwan, Aki Pui-Wah Tse, et al.
Cancer Biology & Medicine|February 18, 2026
Expert consensus on the detection and clinical application of tumor mutational burdenZhenying Guo, Chunwei Xu, Shirong Zhang, et al.
Pageof 13